Cargando…

Recent progress to shorten premarket evaluation and improve patient access to medical devices by the Pharmaceuticals and Medical Devices Agency of Japan

Detalles Bibliográficos
Autores principales:	Handa, Nobuhiro, Takae, Shinichi, Ishii, Kensuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Regulatory and Policy Corner
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749307/ https://www.ncbi.nlm.nih.gov/pubmed/35047777 http://dx.doi.org/10.1136/bmjsit-2019-000014

Ejemplares similares

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Evaluation of reoperations for removal of bioabsorbable plates and screws based on adverse events reports from PMDA, Japan
por: Kobayashi, Tomoko, et al.
Publicado: (2020)

Reporting of Cardiovascular Medical Device Adverse Events to Pharmaceuticals and Medical Devices Agency, Japan()
por: Handa, Nobuhiro, et al.
Publicado: (2015)

Left to Their Own Devices: Breakdowns in United States Medical Device Premarket Review
por: Hines, Jonas Zajac, et al.
Publicado: (2010)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Joint effort: a call for standardization in total joint arthroplasty data reporting
por: Liebeskind, Alexander Y, et al.
Publicado: (2021)

Activity and perspective on quantitative modeling and simulation in Japan: Update from the Pharmaceuticals and Medical Devices Agency
por: Kijima, Shinichi, et al.
Publicado: (2022)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of human embryonic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of autologous human somatic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from the processing of allogeneic human somatic stem cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of autologous human induced pluripotent stem(-like) cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

A study on ensuring the quality and safety of pharmaceuticals and medical devices derived from processing of allogeneic human induced pluripotent stem(-Like) cells()
por: Hayakawa, Takao, et al.
Publicado: (2015)

Postmarket Surveillance of Medical Devices: A Comparison of Strategies in the US, EU, Japan, and China
por: Kramer, Daniel B., et al.
Publicado: (2013)

Premarket Safety and Efficacy Studies for ADHD Medications in Children
por: Bourgeois, Florence T., et al.
Publicado: (2014)

Premarket evaluation of medical devices: a cross-sectional analysis of clinical studies submitted to a German ethics committee
por: Sauerland, Stefan, et al.
Publicado: (2019)

Quantification of US Food and Drug Administration Premarket Approval Statements for High-Risk Medical Devices With Pediatric Age Indications
por: Lee, Samuel J., et al.
Publicado: (2021)

Natural Disasters and the Reshaping of Global Value Chains
por: Freund, Caroline, et al.
Publicado: (2022)

Do Monetary Policy Frameworks Matter in Low-Income Countries?
por: Carare, Alina, et al.
Publicado: (2022)

Calamities, Debt, and Growth in Developing Countries
por: Fan, Rachel Yuting, et al.
Publicado: (2023)

Postmarket Clinical Evidence for High-Risk Therapeutic Medical Devices Receiving Food and Drug Administration Premarket Approval in 2010 and 2011
por: Rathi, Vinay K., et al.
Publicado: (2020)

Medical-device recalls in the UK and the device-regulation process: retrospective review of safety notices and alerts
por: Heneghan, C, et al.
Publicado: (2011)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

How to improve regulatory practices for refurbished medical devices
por: Shukla, Shatrunajay, et al.
Publicado: (2023)

Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017
por: Dubin, Jonathan R., et al.
Publicado: (2021)

400 Exploring the Diversity of Expanded Access Patients at Michigan Medicine
por: Gravelin, Misty, et al.
Publicado: (2023)

390 A Mixed Methods Review of Endpoint Measures Utilized in Adult ADHD Medication Clinical Trial Design
por: Davies, Claire, et al.
Publicado: (2023)

A Novel Isobaric (Gas-Less) Laparoscopic Surgery Device
por: Leahy, Patrick F.
Publicado: (2023)

Economic Implications of Potential Changes to Regulatory and Reimbursement Policies for Medical Devices
por: Reed, Shelby D., et al.
Publicado: (2007)

Estimation of Value-Based Price for 48 High-Technology Medical Devices
por: Hyeraci, Giulia, et al.
Publicado: (2023)

Consideration of and expectations for the Pharmaceuticals, Medical Devices and Other Therapeutic Products Act in Japan()
por: Okada, Kiyoshi, et al.
Publicado: (2015)

Proposed changes to the reimbursement of pharmaceuticals and medical devices in Poland and their impact on market access and the pharmaceutical industry
por: Badora, Karolina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qq5hnm48m076eklviuugo9s007